1. Value in Health Regional Issues
The Patient-Related Burden of Pegylated-Interferon-α Therapy and Adverse Events among Patients with Viral Hepatitis C in Japan 
Hiromitsu Kumada, MD, Marco daCosta DiBonaventura, PhD, Yong Yuan, PhD, Anupama Kalsekar, MS, Lewis Kopenhafer, BS, Ann Tang, PhD, Timothy W. Victor, PhD, Gilbert L’Italien, PhD, Kazuaki Chayama, MD, PhD, Joji Toyota, MD, PhD 
Value in Health Regional Issues 
Volume 3, Pages (May 2014)
DOI: /j.vhri
Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

2. Fig. 1
Prevalence of AEs reported by patients using IFN-α (N = 188). AE, adverse events; IFN-α, Pegylated-Interferon-α.
Value in Health Regional Issues 2014 3, 50-58DOI: ( /j.vhri )
Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions